manual-prevencion

MANUAL SEOM DE PREVENCIÓN Y DIAGNÓSTICO PRECOZ DEL CÁNCER 185 6. BIBLIOGRAFÍA 1. Galceran J., Ameijide A., Carulla M., Mateos A., Quirós J.R., Rojas D. et al.: Cancer Incidence in Spain, 2015. ClinTranslOncol. DOI 10.1007/s12094-016-1607-9Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003; 1 23(1 Suppl):21S. 2. The Health Consequences of Smoking: A Report of the Surgeon General.U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Washington, DC 2004. CDC Publication No.7829. 3. Boffetta P, PershagenG, Jöckel KH, et al. Cigar and pipe smoking and lung cancer risk: amulticenter study fromEurope. J Natl Cancer Inst. 1999;91(8):697. 4. Taylor R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol. 2007;36 (5):1048. 5. Mehra R, Moore BA, Crothers K, et al. The associationbetween marijuana smoking and lung cancer: a systematic review. Arch Intern Med. 2006; 166(13):1359. 6. Landrigan PJ. Asbestos, still a carcinogen. N Engl J Med. 1998;338 (22):1618. 7. Grosche B, Kreuzer M, Kreisheimer M, et al. Lung cancer risk among German male uraniumminers: a cohort study, 1946-1998. Br J Cancer. 2006;95 (9):1280. 8. Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ. 2005;330(7485):223. 9. Barone-Adesi F, Chapman RS, Silverman DT, et al. Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study. BMJ. 2012;345:e5414. 10. Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). LancetOncol. 2013 Aug;14(9):813-22. 11. Olsson AC, Gustavsson P, Kromhout H, et al. Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case- control studies in Europe and Canada. Am J Respir Crit Care Med. 2011 Apr; 183(7):941-8. 12. Brenner DR, Boffetta P, Duell EJ, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer .Consortium. Am J Epidemiol. 2012; 176(7):573. 13. Matakidou A, Eisen T, Houlston RS, et al. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93 (7):825. 14. David E Midthun. Overview of the risk factors, pathology, and clinical manifestations of lung cancer. UpToDate. 15. Shim J, Brindle L, Simon M, et al. A systematic review of symptomatic diagnosis of lung cancer. Fam Pract 2014 Apr;31(2):137-48. 16. Sateia HF, Choi Y, Stewart RW, Peairs K. Screening for lung cancer. SemOncol 2017; 44:74–8 17. Veronesi G, Szabo E, DeCensi A, Guerrieri-Gonzaga A, Bellomi M, Radice D et al. Randomized phase II trial of inhaled budesonide versus placebo in high risk individuals with CT screen-detected lung nodules. Cancer Prev Res 2011; 4 (1): 34-42. 18. Sone S, NkayamaT, HondaT, Tsushima K, Feng L, HaniudaMet al. CT findings of early-stage small cell lung cancer in a low-dose CT screening programme. Lung Cancer 2007; 56: 207-215. 19. The National Lung Screening Trial research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011; 365 (5): 395-409. 20. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry D, Brawley O, et al. Benfits and Harms of CT Screening for Lung Cancer: A Systematic Review. JAMA 2012; 307 (22): 2418-2429. 21. Manser r, Lethaby A, Iving LB, Stone C, Byrnes G, Abramson MJ et al. Screening for lung cancer (Review). Cochrane Database of Systematic Review 2013; 6. Art. No.:CD001991 22. Yousaf-Khan U, van der Aalst C, A de Jong P, Heuvelmans M, Scholten E, Lammers JW et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5 year screening interval. Thorax 2017; 72:48-56. 23. Wille MM, Dirksen A, Ashraf H, Saghir Z, Bach KS, Brodersen J et al. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. Am J RespirCrit Care Med 2016; 193 (5): 542-551. 24. LUSI. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H et al. Randomized Study on early Detection of Lung Cancer with MSCT in Germany. J Thorac Oncol.2015; 10:890-896. 25. InfanteM, CavutoS, LutmanFR, PasseraE, ChiarenzaM, ChiesaGet al. Long-TermFollow-up resultsof theDANTETrial, aRandmoized Study of Lung CnacerScreeening wit Spiral ComutedTomography. Am J RespirCrit Care Med 2015; 191 (10): 1166-1175. 26. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C et al. Annual or biennial CT screening versus observation in heavy smokers: 5 –year results of the MILD trial. Eur J Cancer Prev 2012; 21 (3): 308-315. 27. Field JK, Van Klaveren RV, Pedersen JH, Pastorino U, Paci E, Becker N et al. European Randomized Lung Cancer ScreeningTrials: Post NLST. J SurgOncol 2013: 108:280-286. 28. Huber A, Landau J, Ebner L, BütikoferY, Leidolt L, Brela B et al. Performance of ultralow-dose CTwith iterative reconstruction in lung cancer screening:limiting radiation exposure to the equivalent of conventional chest X-ray imaging. EurRadiol 2016; 26:3643-3652. 29. NCCN v1.2017. LUNG CANCER SCREENING.